刘东方教授治疗慢性心力衰竭的临床经验
曹丽娟,于玲,王凤儒,刘东方
摘要(Abstract)：
刘东方教授认为慢性心力衰竭(CHF)从本质上说是本虚标实之证,心气(阳)虚为本,血瘀、水停为本虚的基本病理改变。治疗上以中医辨证为基础,以益气温阳,活血利水为治疗大法,且善于应用虫类药,随症加减,经临床验证,取得满意的疗效。
关键词(KeyWords)： 慢性心力衰竭;刘东方;临床经验
基金项目(Foundation): 国家自然科学基金项目(81102590);; 国家科技重大专项课题(2009ZX09103-425);; 优秀创新人才支持计划(051267)
作者(Author): 曹丽娟,于玲,王凤儒,刘东方
参考文献(References)：
- [1] Sharma A,Lavie CJ,Borer JS,et al. Meta-analysis of the relation of body mass index to all-cause and cardiovascular mortality and hospitalization in patients with chronic heart failure[J]. American Journal of Cardiology,2015,115(10):1428-1434.
- [2] Berg D,Postuma RB,Bloem B,et al. Time to redefine PD introductory statement of the MDS task force on the definition of Parkinson′s disease[J]. Movement Disorders,2014,29(4):454-462.
- [3] Lok DJ,Lok SI,Bruggink-AndréDe La Porte PW,et al.Galectin-3 is an independent marker for ventricular remodeling and mortality in patients with chronic heart failure[J].Clinical Research in Cardiology,2013,102(2):103-110.
- [4] Benjamin EJ,Blaha MJ,Chiuve SE,et al. Heart disease and stroke statistics′2017 Update:a report from the American heart association[J]. Circulation,2017,135(10):e146-e603.
- [5]周仲英.中医内科学[M].北京:中国中医药出版社,2004:91-100,131-142,345-356.
- [6]刘纯.刘纯医学全集[M].北京:人民卫生出版社,1986:966.
- [7]韩学艳,刘秋芹,姜枫,等.基于数据挖掘的心力衰竭常见证型用药规律分析[J].河南中医,2018,38(1):81-85.
- [8]焦雄文,段颖.黄芪注射液对充血性心力衰竭左心室重构影响的临床研究[J].陕西中医学院学报,2006,29(3):19.
- [9]褚书豪,汪小彩,冯良.太子参化学成分及其药理作用研究进展[J].光明中医,2016,31(7):1047-1048.
- [10]朱步先,朱胜华,蒋鼎,等.朱良春用药经验集[M].长沙:湖南科学技术出版社,2000:11.
- [11]程志红,萧伟,王振中,等.泽泻调血脂活性成分及其药理和临床应用研究进展[J].中草药,2015,46(22):3420-3426.
- [12]刘文雅,王曙东.地龙药理作用研究进展[J].中国中西医结合杂志,2013,33(2):282-285.
- [13]杨洪雁,杜智恒,白秀娟.水蛭药理作用的研究进展[J].东北农业大学学报,2012,43(3):128-133.
- [14]刘晓亚,房丹.中药全蝎药理作用研究进展[J].内蒙古中医药,2014,33(14):114-116.
- [15]韩淑娴,游云.三七总皂苷心脑血管药理作用及其溶血反应[J].中国中药杂志,2016,41(5):818-822.
- [16]王龙,白云.近10年白术多糖的研究进展[J].按摩与康复医学,2018,9(17):88-89.
- [17]陆山红,赵荣华,么晨,等.砂仁的化学及药理研究进展[J].中药药理与临床,2016,32(1):227-230.
- [18] Kalter-Leibovici O,Freimark D,Freedman LS,et al. Disease management in the treatment of patients with chronic heart failure who have universal access to health care:A randomized controlled trial[J]. BMC Medicine,2017,15(1):90.
- [19] Zhang KJ,Zhu JZ,Bao XY,et al. Shexiang Baoxin Pills for coronary heart disease in animal models:Preclinical evidence and promoting angiogenesis mechanism[J]. Frontiers in Pharmacology,2017,8:404.
- [20]李芳.真武汤加味治疗慢性心力衰竭31例[J].河南中医,2017,37(9):1555-1557.